Millions in Spain Suffer Sleepless Nights Due to Restless legs syndrome
Restless Legs Syndrome (RLS), a condition causing an frequently enough overwhelming urge to move the legs, affects a significant portion of the Spanish population, leading to widespread sleep disruption and impacting daily life. Recognized on September 23rd as “The Day of” RLS, the condition demands increased awareness and attention to its consequences.
Approximately ten percent of adults in Spain experience RLS, manifesting as uncomfortable sensations – tingling, itching, or pain – in the legs that are only temporarily relieved by movement. these symptoms are particularly pronounced in the evenings and at night, severely hindering relaxation and causing significant sleep problems. While it can occur at any age, diagnosis in children (affecting around four percent) is often delayed due to symptoms mimicking growing pains or ADHD. Alarmingly, it takes an average of over ten years to recieve a correct diagnosis in Spain.
women are twice as likely to be affected as men, frequently enough linked to iron deficiencies stemming from pregnancy or heavy menstruation. Though,genetics play a considerable role,with a hereditary factor present in approximately 65 percent of cases. The condition is also associated with other health issues like diabetes, kidney problems, and certain nerve diseases.
Treatment for RLS varies depending on the individual. Iron supplementation can be effective for some, while others benefit from specific medication.The Spanish Sleep Society (SEN) reports that appropriate treatment can substantially improve sleep quality and overall quality of life for many patients. Due to the fluctuating and chronic nature of the symptoms, ongoing monitoring by a neurologist is crucial.
One medication used in Spain for RLS treatment is Neupro, a transdermal plaster delivering rotigotine, a dopamine agonist. Rotigotine mimics the effects of dopamine, a neurotransmitter involved in movement and sensation. Neupro provides a consistent release of the medication over 24 hours, reducing the urge to move the legs in approximately 70% of patients, according to studies.
Common side effects of Neupro include skin irritation, nausea, and dizziness. It is not recommended for pregnant or breastfeeding women, or individuals with severe liver or heart disease. Those considering Neupro should consult with a doctor or specialist; in Spain, it may be reimbursable through public health services with a proper diagnosis.
Despite the prevalence of RLS, its underlying cause remains unknown. This underscores the importance of raising awareness and facilitating early diagnosis to improve the lives of the millions of Spaniards affected by this often debilitating condition.
for further data about Restless Legs Syndrome in the Netherlands, visit the Restless legs Foundation website: https://www.stichting-restless-legs.nl/.
